Noramco, Inc. – Trademark Portfolio
Entity Type: 03
Noramco, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include NORAMCO and PURISYS. The owner is based in Queens Village, NY.
97-11 22ND ST.
Queens Village, NY
Showing of trademarks Trademarks
Trademark Classifications
Noramco, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Noramco, Inc. have?
Noramco, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 3 cancelled.
What trademark classes does Noramco, Inc. file in?
Noramco, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 30 (Staple Foods), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Noramco, Inc.'s most well-known trademarks?
Noramco, Inc.'s registered trademark portfolio includes well-known marks such as NORAMCO and PURISYS. These are among 2 currently registered trademarks in the portfolio.
What is Noramco, Inc.'s trademark registration success rate?
Noramco, Inc. has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.